Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01220193 · ClinicalTrials.gov registry record

Evaluation of RTVue in Corneal Measurement

A clinical trial of Cataract Surgery and Normal Cornea, sponsored by Optovue.

Completed
Registry status
196
Enrollment target
2
Study locations

NCT01220193 is a study of Cataract Surgery and Normal Cornea that has completed, run by Optovue. The registered enrollment target is 196 participants, above the 118-participant average among 7 other Cataract Surgery trials with a reported enrollment target (66% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01220193, a study of Cataract Surgery and Normal Cornea, has completed, sponsored by Optovue.

COMPLETED
Registry status
196 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to evaluate RTVue measurement of the cornea in various ocular conditions to include normal, pathology, post refractive surgery and cataract.

Study Locations (2)

California

  • Gordon Binder & Weiss Vision Institute - San Diego

New York

  • Brass Eye Center - Latham

Trial Details

FieldValue
Enrollment Target 196 participants
Start Date 2009-04
Est. Completion 2010-12

Sponsor

Optovue

12 total trials

What the Registry Record Tells You About NCT01220193

The ClinicalTrials.gov registry entry for NCT01220193 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 196 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 118-participant average among 7 other Cataract Surgery trials with a reported enrollment target (66% higher). The listed sponsor is Optovue, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Cataract Surgery appearing as the primary indexed condition, and to 0 interventions.

NCT01220193 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, New York.

Frequently Asked Questions

What is clinical trial NCT01220193 about?

NCT01220193 is a clinical study titled "Evaluation of RTVue in Corneal Measurement". The purpose of this study is to evaluate RTVue measurement of the cornea in various ocular conditions to include normal, pathology, post refractive surgery and cataract.

What is the current status of trial NCT01220193?

This trial is currently completed. The enrollment target is 196 participants. The study started on 2009-04. Estimated completion is 2010-12.

What conditions does trial NCT01220193 study?

This clinical trial studies the following conditions: Cataract Surgery, Normal Cornea, Post Laser Refractive Surgery, Cornea Pathology.

Who is sponsoring clinical trial NCT01220193?

This trial is sponsored by Optovue, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01220193 being conducted?

This trial has 2 study locations across California, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cataract Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.